44.氫分子醫學學者介紹 大野欽司 Kinji Ohno

氫分子醫學學者介紹  大野欽司 Kinji Ohno

KinjiOhno

Division of Neurogenetics, Centerfor Neurological Diseases and Cancer, Nagoya University GraduateSchool of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550,Japan

Fax: +81 52 744 2449

ohnok@med.nagoya-u.ac.jp

、健康氫水、水素水、負電位、ORP、抗氧化、抗自由基 、氫分子醫學、氫水、Hydrogen water、氫氣、氫、氫水、台灣氫水實驗室、台灣氫水研究中心、氫思語、孫學軍、太田成男、鹼性離子水、小分子水、能量水、電解水、富氫水、負氫水、活水、健康、養生、活力、Kinji Ohno MD, PhDProfessor, Department of Neurogenetics and Bioinformatics, Nagoya University Graduate School of Medicine

http://w3serv.nagoya-u.ac.jp/coemed/en/members/2010/post-6/

名古屋大學Nagoya University醫學系研究科大野欽司教授Kinji Ohno是該大學神經遺傳科學和生物資訊學專業教授,　

在氫氣生物學效應研究方面有重要貢獻，

他的小組最早提出氫氣是一種信號調節分子，發現對哮喘、帕金森病、子宮內缺血導致的腦損傷、慢性氫氣產生的基因表達調節等方面有重要貢獻，一直走在氫氣生物學效應研究前列，至今發表氫氣相關英文學術論文11篇。

1.       Sobue S, Yamai K, Ito M, Ohno K,Ito M, Iwamoto T, Qiao S, Ohkuwa T, Ichihara M. Simultaneous oral andinhalational intake of molecular hydrogen additively suppresses signaling pathwaysin rodents. Mol Cell Biochem. 2015 Feb 24.

2.       Mano Y, Kotani T, Ito M,Nagai T, Ichinohashi Y, Yamada K, Ohno K, Kikkawa F, Toyokuni S. Maternal molecularhydrogen administration ameliorates rat fetal hippocampal damagecaused by in utero ischemia-reperfusion. Free Radic Biol Med. 2014Apr;69:324-30.

3.       Iio A, Ito M, Itoh T,Terazawa R, Fujita Y, Nozawa Y, Ohsawa I, Ohno K, Ito M. Molecular hydrogen attenuates fattyacid uptake and lipid accumulation through downregulating CD36 expression inHepG2 cells. Med Gas Res. 2013 Mar 1;3(1):6.

4.       Ohta S, Nakao A, Ohno K.The 2011 Medical Molecular Hydrogen Symposium: An inaugural symposium of thejournal Medical Gas Research. Med Gas Res. 2011 Jun 7;1(1):10.

5.       Ohno K, Ito M, Ichihara M, Ito M. Molecular hydrogen as anemerging therapeutic medical gas for neurodegenerative and other diseases. OxidMed Cell Longev. 2012;2012:353152. doi: 10.1155/2012/353152.

6.       Ito M, Hirayama M, YamaiK, Goto S, Ito M, Ichihara M, Ohno K.Drinkinghydrogen water and intermittent hydrogen gas exposure, but not lactulose orcontinuous hydrogen gas exposure, prevent 6-hydorxydopamine-inducedParkinson's diseasein rats. Med Gas Res. 2012 May 20;2(1):15.

7.       Ito M, Ibi T, Sahashi K,Ichihara M, Ito M, Ohno K. Open-label trial andrandomized, double-blind, placebo-controlled, crossover trial ofhydrogen-enriched water for mitochondrial and inflammatorymyopathies. Med Gas Res. 2011 Oct 3;1(1):24.

8.       Itoh T, Hamada N, TerazawaR, Ito M, Ohno K,Ichihara M, Nozawa Y, Ito M. Molecular hydrogen inhibitslipopolysaccharide/interferon γ-induced nitric oxide production throughmodulation of signal transduction in macrophages. Biochem Biophys Res Commun.2011 Jul 22;411(1):143-9.

9.       Fu Y, Ito M, Fujita Y, ItoM, Ichihara M, Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, Ohsawa I,Ohta S, Ohno K. Molecularhydrogen is protective against 6-hydroxydopamine-induced nigrostriataldegeneration in a rat model ofParkinson's disease. Neurosci Lett. 2009 Apr3;453(2):81-5.

10.   Itoh T, Fujita Y, Ito M,Masuda A, Ohno K,Ichihara M, Kojima T, Nozawa Y, Ito M. Molecular hydrogen suppressesFcepsilonRI-mediated signal transduction and prevents degranulation of mastcells. Biochem Biophys Res Commun. 2009 Nov 27;389(4):651-6.

11.   Fu Y, Ito M, Fujita Y, ItoM, Ichihara M, Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, Ohsawa I,Ohta S, Ohno K.Molecular hydrogen is protective against 6-hydroxydopamine-inducednigrostriatal degeneration in a rat model of Parkinson's disease. NeurosciLett. 2009 Apr 3;453(2):81-5.

引用文章出處：:http://blog.sciencenet.cn/blog-41174-872424.html